Medtronic plc — Director's Dealing 2019

Mar 6, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-03-04

Reporting Person: Lenehan James T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-04	Ordinary Shares	M	2671	$29.96	Acquired	51808	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-04	Stock Option (Right to Buy)	$29.96	M	2671	Disposed	2019-04-27	Ordinary Shares (2671)	Direct

Footnotes

F1: This balance increased by 403 shares due to exempt transactions such as dividend reinvestment

F2: This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.